Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

402
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
402
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

282
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
282
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

205
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
205
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

310
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
310
Venous Return01:04

Venous Return

11.8K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
11.8K
Cerebral Hemispheres01:05

Cerebral Hemispheres

2.1K
The human brain, a complex organ, is functionally divided into two cerebral hemispheres—left and right. These hemispheres are interconnected by a structure of paramount importance, the corpus callosum. This substantial bundle of neural fibers is not just a bridge between the hemispheres but a crucial element for the brain's comprehensive functioning. It enables efficient communication between the two hemispheres, allowing each side of the brain to control and receive sensory and motor...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Prehospital time efficiency in the Portuguese Stroke Fast-Track pathway: a nationwide observational study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Blood pressure management in patients receiving rescue stenting after failed endovascular treatment in large vessel occlusion acute ischaemic stroke: a multicentre registry.

European stroke journal·2026
Same author

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

JAMA network open·2026
Same author

Prodromal neurology: Is this the end of semiology?

Journal of the neurological sciences·2026
Same author

Asundexian for Secondary Stroke Prevention.

The New England journal of medicine·2026

Related Experiment Video

Updated: Jan 20, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.1K

Cerebral Venous Thrombosis: an Update.

José M Ferro1,2, Diana Aguiar de Sousa3,4

  • 1Serviço de Neurologia, Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa Norte, Instituto de Medicina Molecular, Lisbon, Portugal. jmferro@medicina.ulisboa.pt.

Current Neurology and Neuroscience Reports
|August 24, 2019
PubMed
Summary

Recent advances in cerebral venous thrombosis (CVT) management show declining patient severity and mortality. Key strategies include treating associated conditions, anticoagulation, seizure prevention, and neurosurgery for severe cases.

Keywords:
AnticoagulantsCT venographyCerebral veinCerebral venous thrombosisDabigatranDecompressive surgeryDural sinus thrombosisHemicraniectomyIntracranial hypertensionMR venographyMRIPregnancyPrognosisSeizuresThrombectomyThrombolysis

More Related Videos

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.7K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.0K

Related Experiment Videos

Last Updated: Jan 20, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.1K
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.7K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.0K

Area of Science:

  • Neurology
  • Vascular Medicine
  • Thrombosis Research

Background:

  • Cerebral venous thrombosis (CVT) is a rare but serious condition affecting venous blood drainage from the brain.
  • Recent data indicate a shift towards less severe presentations and improved outcomes in CVT patients over time.

Purpose of the Study:

  • To provide a comprehensive summary of the latest advancements in the clinical management of cerebral venous thrombosis.
  • To highlight evolving trends and evidence-based strategies for CVT treatment.

Main Methods:

  • Review of recent literature and clinical findings related to CVT management.
  • Analysis of trends in patient presentation, risk factors, and treatment outcomes.

Main Results:

  • A declining trend in the frequency of focal deficits and coma among CVT patients.
  • Identification of anemia and obesity as significant risk factors for CVT.
  • Increased CVT risk observed during the postpartum period, particularly in the initial months after delivery.
  • Successful recovery rates of up to one-third in comatose CVT patients with appropriate interventions.
  • Standard management includes addressing comorbidities, parenteral heparin anticoagulation, seizure prophylaxis, and decompressive surgery for herniation risk.

Conclusions:

  • Effective management of CVT involves a multi-faceted approach, including anticoagulation for 3-12 months post-acute phase.
  • Emerging evidence from randomized trials on endovascular therapies and novel anticoagulants (e.g., dabigatran vs. warfarin) promises to further refine CVT treatment protocols.